Unknown

Dataset Information

0

4-[4-(4-Fluoro-phen-yl)-2-methyl-5-oxo-2,5-dihydro-isoxazol-3-yl]-1-methyl-pyridinium iodide-4-[3-(4-fluoro-phen-yl)-2-methyl-5-oxo-2,5-dihydro-isoxazol-4-yl]-1-methyl-pyridinium iodide (0.6/0.4).


ABSTRACT: The crystal structure of the title compound, C(16)H(16)FN(2)O(2) (+)·I(-), was determined as part of a study of the biological activity of isoxazolone derivatives as p38 mitogen-activated protein kinase (MAPK) inhibitors. The X-ray crystal structure of 4-[4-(4-fluoro-phenyl)-2-methyl-5-oxo-2,5-dihydro-isoxazol-3-yl]-1-methyl-pyridinium iodide showed the presence of the regioisomer 4-[3-(4-fluoro-phenyl)-2-methyl-5-oxo-2,5-dihydro-isoxazol-4-yl]-1-methyl-pyridinium iodide. The synthesis of the former compound was achieved by reacting 4-(4-fluoro-phenyl)-3-(4-pyridyl)isoxazol-5(2H)-one after treatment with Et(3)N in dimethyl-formamide, with iodo-methane. The unexpected formation of the regioisomer could be explained by a rearrangement occurring via aziridine of the isoxazolone compound. The regioisomers have site occupancies of 0.632?(4)/0.368?(4). The two six members rings make a dihedral angle of 66.8?(2)°.

SUBMITTER: Margutti S 

PROVIDER: S-EPMC2915348 | biostudies-literature | 2007 Dec

REPOSITORIES: biostudies-literature

altmetric image

Publications

4-[4-(4-Fluoro-phen-yl)-2-methyl-5-oxo-2,5-dihydro-isoxazol-3-yl]-1-methyl-pyridinium iodide-4-[3-(4-fluoro-phen-yl)-2-methyl-5-oxo-2,5-dihydro-isoxazol-4-yl]-1-methyl-pyridinium iodide (0.6/0.4).

Margutti Simona S   Schollmeyer Dieter D   Laufer Stefan S  

Acta crystallographica. Section E, Structure reports online 20071218 Pt 1


The crystal structure of the title compound, C(16)H(16)FN(2)O(2) (+)·I(-), was determined as part of a study of the biological activity of isoxazolone derivatives as p38 mitogen-activated protein kinase (MAPK) inhibitors. The X-ray crystal structure of 4-[4-(4-fluoro-phenyl)-2-methyl-5-oxo-2,5-dihydro-isoxazol-3-yl]-1-methyl-pyridinium iodide showed the presence of the regioisomer 4-[3-(4-fluoro-phenyl)-2-methyl-5-oxo-2,5-dihydro-isoxazol-4-yl]-1-methyl-pyridinium iodide. The synthesis of the fo  ...[more]

Similar Datasets

| S-EPMC3089274 | biostudies-literature
| S-EPMC2915214 | biostudies-literature
| S-EPMC2983633 | biostudies-literature
| S-EPMC3515270 | biostudies-literature
| S-EPMC3295503 | biostudies-literature
| S-EPMC4719983 | biostudies-literature
| S-EPMC3772492 | biostudies-literature
| S-EPMC3393918 | biostudies-literature
| S-EPMC2960186 | biostudies-literature
| S-EPMC2969331 | biostudies-literature